Laboratory Medicine ›› 2025, Vol. 40 ›› Issue (5): 428-436.DOI: 10.3969/j.issn.1673-8640.2025.05.003
Previous Articles Next Articles
WU Yazhou1, LI Hanhua2, MENG Leijun2, CHEN Xuefei3, SUN Yuhan2, WENG Wenhao2, ZHENG Bing1()
Received:
2024-08-12
Revised:
2025-02-17
Online:
2025-05-30
Published:
2025-06-04
CLC Number:
WU Yazhou, LI Hanhua, MENG Leijun, CHEN Xuefei, SUN Yuhan, WENG Wenhao, ZHENG Bing. Fusobacterium nucleatum promoting chemoresistance of colorectal cancer cells via lncRNA XIST[J]. Laboratory Medicine, 2025, 40(5): 428-436.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2025.05.003
引物名称 | 正向引物(5'~3') | 反向引物(5'~3') |
---|---|---|
siNC | UUCUCCGAACGUGUCACGUTT | ACGUGACACGUUCGGAGAATT |
siXIST | GCUGACUACCUGAGAUUUATT | UAAAUCUCAGGUAGUCAGCTT |
引物名称 | 正向引物(5'~3') | 反向引物(5'~3') |
---|---|---|
siNC | UUCUCCGAACGUGUCACGUTT | ACGUGACACGUUCGGAGAATT |
siXIST | GCUGACUACCUGAGAUUUATT | UAAAUCUCAGGUAGUCAGCTT |
引物名称 | 正向引物(5'~3') | 反向引物(5'~3') |
---|---|---|
具核梭杆菌 | GCTTGAAATGGAAGCTACAAGAGA | GGGTCAGAACCAACTCCTACAA |
PGT | ATCCCCAAAGCACCTGGTTT | AGAGGCCAAGATAGTCCTGGTAA |
引物名称 | 正向引物(5'~3') | 反向引物(5'~3') |
---|---|---|
具核梭杆菌 | GCTTGAAATGGAAGCTACAAGAGA | GGGTCAGAACCAACTCCTACAA |
PGT | ATCCCCAAAGCACCTGGTTT | AGAGGCCAAGATAGTCCTGGTAA |
引物名称 | 正向引物(5'~3') | 反向引物(5'~3') |
---|---|---|
β-actin | CATGTACGTTGCTATCCAGGC | CTCCTTAATGTCACGCACGAT |
lncRNA XIST | GGAAAAGTGGCCGCCATTTT | ACATATGACAACGCCTGCCA |
lncRNA snaR | CACGTGGTGGCAAAGGAAAG | TCGTGACTTCCATTGTGGGG |
lncRNA UCA1 | TCCTTCCAAATGGCCATCCC | ACCAAAGCCTTTTGTCCCCA |
lncRNA SLC25A25-AS1 | GCTTGGACTTCCTGGAGGAC | GGAGGAGGCAGGAGAGAGAA |
Linc00152 | TCTCCTTGGCTTGCAGATGG | GACTGGCCAGACAAATGGGA |
lncRNA H19 | AGACACCATCGGAACAGCAG | ATGATGAGTCCAGGGCTCCT |
lncRNA MALAT1 | GGACTTGCCTCAACTCCCTC | GCCCTCTCAGCCACTCAAAT |
lncRNA CRNDE | GGCGCTAACGGTCGGTAAC | TTCTGCGTGACAACTGAGGA |
lncRNA MEG3 | GGCCTGTCTACACTTGCTGT | CAACAGCCCTGTGAGGTAGG |
lncRNA PCAT-1 | AAACCGCAACATCACCAACG | TTCACCGTGTTAGCCAGGAC |
Linc00261 | AGGATTCTGCATGTGGGTGG | GCCTTTGGGGAAATGCTTGG |
lncRNA PVT1 | TGAGGAGCTGCATCTACCCT | GGGTGGACAGGTAACAGGTG |
lncRNA MIR100HG | GGGCTGCGGAATTTTGGAAG | TTGCACTGGGGAGACATTCC |
lncRNA TUG1 | TGGTATGGCTGGCCTTTCTG | CTGAGAGCCCAACTGTCCTG |
lncRNA HOTAIR | GGAAGCGAAGGGGTTGTGTA | GCAGGAGGAAGTTCAGGCAT |
引物名称 | 正向引物(5'~3') | 反向引物(5'~3') |
---|---|---|
β-actin | CATGTACGTTGCTATCCAGGC | CTCCTTAATGTCACGCACGAT |
lncRNA XIST | GGAAAAGTGGCCGCCATTTT | ACATATGACAACGCCTGCCA |
lncRNA snaR | CACGTGGTGGCAAAGGAAAG | TCGTGACTTCCATTGTGGGG |
lncRNA UCA1 | TCCTTCCAAATGGCCATCCC | ACCAAAGCCTTTTGTCCCCA |
lncRNA SLC25A25-AS1 | GCTTGGACTTCCTGGAGGAC | GGAGGAGGCAGGAGAGAGAA |
Linc00152 | TCTCCTTGGCTTGCAGATGG | GACTGGCCAGACAAATGGGA |
lncRNA H19 | AGACACCATCGGAACAGCAG | ATGATGAGTCCAGGGCTCCT |
lncRNA MALAT1 | GGACTTGCCTCAACTCCCTC | GCCCTCTCAGCCACTCAAAT |
lncRNA CRNDE | GGCGCTAACGGTCGGTAAC | TTCTGCGTGACAACTGAGGA |
lncRNA MEG3 | GGCCTGTCTACACTTGCTGT | CAACAGCCCTGTGAGGTAGG |
lncRNA PCAT-1 | AAACCGCAACATCACCAACG | TTCACCGTGTTAGCCAGGAC |
Linc00261 | AGGATTCTGCATGTGGGTGG | GCCTTTGGGGAAATGCTTGG |
lncRNA PVT1 | TGAGGAGCTGCATCTACCCT | GGGTGGACAGGTAACAGGTG |
lncRNA MIR100HG | GGGCTGCGGAATTTTGGAAG | TTGCACTGGGGAGACATTCC |
lncRNA TUG1 | TGGTATGGCTGGCCTTTCTG | CTGAGAGCCCAACTGTCCTG |
lncRNA HOTAIR | GGAAGCGAAGGGGTTGTGTA | GCAGGAGGAAGTTCAGGCAT |
组别 | HCT116细胞 | SW480细胞 |
---|---|---|
5-FU组 | 10.71±0.50 | 11.12±0.37 |
E.coli/5-FU组 | 10.70±0.38 | 11.09±0.27 |
Fn/5-FU组 | 17.20±0.91* | 18.05±0.69* |
OXA组 | 5.55±0.18 | 5.80±0.37 |
E.coli/OXA组 | 5.64±0.28 | 5.82±0.39 |
Fn/OXA组 | 9.88±0.53# | 9.77±0.48# |
组别 | HCT116细胞 | SW480细胞 |
---|---|---|
5-FU组 | 10.71±0.50 | 11.12±0.37 |
E.coli/5-FU组 | 10.70±0.38 | 11.09±0.27 |
Fn/5-FU组 | 17.20±0.91* | 18.05±0.69* |
OXA组 | 5.55±0.18 | 5.80±0.37 |
E.coli/OXA组 | 5.64±0.28 | 5.82±0.39 |
Fn/OXA组 | 9.88±0.53# | 9.77±0.48# |
组别 | 例数 | 具核梭杆菌 | lncRNA XIST |
---|---|---|---|
未复发组 | 10 | 1.00±0.52 | 1.00±0.45 |
复发组 | 10 | 1.84±0.81* | 2.05±0.95** |
组别 | 例数 | 具核梭杆菌 | lncRNA XIST |
---|---|---|---|
未复发组 | 10 | 1.00±0.52 | 1.00±0.45 |
复发组 | 10 | 1.84±0.81* | 2.05±0.95** |
组别 | HCT116细胞 | SW480细胞 |
---|---|---|
对照组 | 1.00±0.11 | 1.00±0.10 |
敲减组 | 0.61±0.08* | 0.54±0.04* |
组别 | HCT116细胞 | SW480细胞 |
---|---|---|
对照组 | 1.00±0.11 | 1.00±0.10 |
敲减组 | 0.61±0.08* | 0.54±0.04* |
组别 | HCT116/5-FU细胞/(μg·mL-1) | SW480/5-FU细胞/(μg·mL-1) |
---|---|---|
对照组 | 99.17±7.51 | 105.70±7.44 |
敲减组 | 46.67±2.01* | 46.40±2.92* |
组别 | HCT116/5-FU细胞/(μg·mL-1) | SW480/5-FU细胞/(μg·mL-1) |
---|---|---|
对照组 | 99.17±7.51 | 105.70±7.44 |
敲减组 | 46.67±2.01* | 46.40±2.92* |
[1] | SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3):209-249. |
[2] | BILLER L H, SCHRAG D. Diagnosis and treatment of metastatic colorectal cancer:a review[J]. JAMA, 2021, 325(7):669-685. |
[3] | AL BITAR S, EL-SABBAN M, DOUGHAN S, et al. Molecular mechanisms targeting drug-resistance and metastasis in colorectal cancer:updates and beyond[J]. World J Gastroenterol, 2023, 29(9):1395-1426. |
[4] | KRIEGER M, ABDELRAHMAN Y M, CHOI D, et al. Stratification of Fusobacterium nucleatum by local health status in the oral cavity defines its subspecies disease association[J]. Cell Host Microbe, 2024, 32(4):479-488. |
[5] | WANG N, FANG J Y. Fusobacterium nucleatum,a key pathogenic factor and microbial biomarker for colorectal cancer[J]. Trends Microbiol, 2023, 31(2):159-172. |
[6] | XU C, FAN L, LIN Y, et al. Fusobacterium nucleatum promotes colorectal cancer metastasis through miR-1322/CCL20 axis and M2 polarization[J]. Gut Microbes, 2021, 13(1):1980347. |
[7] | ZHANG S, YANG Y, WENG W, et al. Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer[J]. J Exp Clin Cancer Res, 2019, 38(1):14. |
[8] | LIU Y, BABA Y, ISHIMOTO T, et al. Fusobacterium nucleatum confers chemoresistance by modulating autophagy in oesophageal squamous cell carcinoma[J]. Br J Cancer, 2021, 124(5):963-974. |
[9] | CHEN D L, XU R H. The emerging role of long non-coding RNAs in the drug resistance of colorectal cancer[J]. Int J Clin Exp Pathol, 2018, 11(10):4735-4743. |
[10] | BIAN Z, JIN L, ZHANG J, et al. LncRNA-UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-5p[J]. Sci Rep, 2016, 6:23892. |
[11] |
HAN P, LI J W, ZHANG B M, et al. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling[J]. Mol Cancer, 2017, 16(1):9.
DOI PMID |
[12] |
LEE H, KIM C, KU J L, et al. A long non-coding RNA snaR contributes to 5-fluorouracil resistance in human colon cancer cells[J]. Mol Cells, 2014, 37(7):540-546.
DOI PMID |
[13] | LI C, GAO Y, LI Y, et al. TUG1 mediates methotrexate resistance in colorectal cancer via miR-186/CPEB2 axis[J]. Biochem Biophys Res Commun, 2024, 691:149346. |
[14] |
LI J, LIU H, YU J, et al. Chemoresistance to doxorubicin induces epithelial-mesenchymal transition via upregulation of transforming growth factor β signaling in HCT116 colon cancer cells[J]. Mol Med Rep, 2015, 12(1):192-198.
DOI PMID |
[15] |
LI P, ZHANG X, WANG H, et al. MALAT1 is associated with poor response to oxaliplatin-based chemotherapy in colorectal cancer patients and promotes chemoresistance through EZH2[J]. Mol Cancer Ther, 2017, 16(4):739-751.
DOI PMID |
[16] | LI Y, HUANG S, LI Y, et al. Decreased expression of lncRNA SLC25A25-AS1 promotes proliferation,chemoresistance,and EMT in colorectal cancer cells[J]. Tumour Biol, 2016, 37(10):14205-14215. |
[17] |
LU Y, ZHAO X, LIU Q, et al. LncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/β-catenin signaling[J]. Nat Med, 2017, 23(11):1331-1341.
DOI PMID |
[18] |
PING G, XIONG W, ZHANG L, et al. Silencing long noncoding RNA PVT1 inhibits tumorigenesis and cisplatin resistance of colorectal cancer[J]. Am J Transl Res, 2018, 10(1):138-149.
DOI PMID |
[19] |
QIAO L, LIU X, TANG Y, et al. Knockdown of long non-coding RNA prostate cancer-associated ncRNA transcript 1 inhibits multidrug resistance and c-Myc-dependent aggressiveness in colorectal cancer Caco-2 and HT-29 cells[J]. Mol Cell Biochem, 2018, 441(1-2):99-108.
DOI PMID |
[20] |
WANG M, HU H, WANG Y, et al. Long non-coding RNA TUG1 mediates 5-fluorouracil resistance by acting as a ceRNA of miR-197-3p in colorectal cancer[J]. J Cancer, 2019, 10(19):4603-4613.
DOI PMID |
[21] | WANG Z K, YANG L, WU L L, et al. Long non-coding RNA LINC00261 sensitizes human colon cancer cells to cisplatin therapy[J]. Braz J Med Biol Res, 2017, 51(2):e6793. |
[22] | XIAO Z, QU Z, CHEN Z, et al. LncRNA HOTAIR is a prognostic biomarker for the proliferation and chemoresistance of colorectal cancer via miR-203a-3p-mediated Wnt/β-catenin signaling pathway[J]. Cell Physiol Biochem, 2018, 46(3):1275-1285. |
[23] | YIN D D, LIU Z J, ZHANG E, et al. Decreased expression of long noncoding RNA MEG3 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer[J]. Tumour Biol, 2015, 36(6):4851-4859. |
[24] |
YUE B, CAI D, LIU C, et al. Linc00152 functions as a competing endogenous RNA to confer oxaliplatin resistance and holds prognostic values in colon cancer[J]. Mol Ther, 2016, 24(12):2064-2077.
DOI PMID |
[25] | FAN Y, PEDERSEN O. Gut microbiota in human metabolic health and disease[J]. Nat Rev Microbiol, 2021, 19(1):55-71. |
[26] | OU S, WANG H, TAO Y, et al. Fusobacterium nucleatum and colorectal cancer:from phenomenon to mechanism[J]. Front Cell Infect Microbiol, 2022, 12:1020583. |
[27] | RUBINSTEIN M R, BAIK J E, LAGANA S M, et al. Fusobacterium nucleatum promotes colorectal cancer by inducing Wnt/β-catenin modulator Annexin A1[J]. EMBO Rep, 2019, 20(4):e47638. |
[28] | CHEN S, ZHANG L, LI M, et al. Fusobacterium nucleatum reduces METTL3-mediated m6A modification and contributes to colorectal cancer metastasis[J]. Nat Commun, 2022, 13(1):1248. |
[29] | YU T, GUO F, YU Y, et al. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy[J]. Cell, 2017, 170(3):548-563. |
[30] |
KOPP F, MENDELL J T. Functional classification and experimental dissection of long noncoding RNAs[J]. Cell, 2018, 172(3):393-407.
DOI PMID |
[31] | CHEN Z Y, WANG X Y, YANG Y M, et al. LncRNA SNHG16 promotes colorectal cancer cell proliferation,migration,and epithelial-mesenchymal transition through miR-124-3p/MCP-1[J]. Gene Ther, 2022, 29(3-4):193-205. |
[32] |
LIU A, LIU L, LU H. LncRNA XIST facilitates proliferation and epithelial-mesenchymal transition of colorectal cancer cells through targeting miR-486-5p and promoting neuropilin-2[J]. J Cell Physiol, 2019, 234(8):13747-13761.
DOI PMID |
[1] | YU Jiajie, ZHANG Zhizhi, LUO Qingqiong, KE Xing. Predicting early colorectal tumor risk using a deep learning model based on multiple serum tumor markers [J]. Laboratory Medicine, 2025, 40(3): 253-258. |
[2] | SHEN Ximin, ZHANG Lei, QUAN Heng, NIU Ziguang, XIA Dongge, ZHANG Rulin. Clinical significance of serum lncRNA NEAT1 for multiple myeloma patients with kidney injury [J]. Laboratory Medicine, 2025, 40(1): 32-36. |
[3] | ZHANG Xiaoke, CHU Yanrong, WANG Rong, CUI Facai. Serum lncRNA HAND2-AS1 expression in cervical cancer patients and its effect on proliferation,invasion and migration of cervical cancer Caski cells [J]. Laboratory Medicine, 2024, 39(5): 429-437. |
[4] | ZHENG Hui, CHEN Yingxiu, YE Lüyin, LU Renquan, GUO Lin. Relationship between peripheral blood T lymphocyte subsets and tumor progression in patients with colorectal cancer [J]. Laboratory Medicine, 2024, 39(4): 330-335. |
[5] | XU Yunchuan, HUANGFU Yuchan, MA Yanhui. Effect of highly expressed IL-35 on Th1 and Th17 plasticity in colorectal cancer [J]. Laboratory Medicine, 2024, 39(4): 343-350. |
[6] | FANG Dandong, CHENG Gang, HUANG Wei, LIU Xiaonan, MAO Jian, HOU Baosen, LIU Shimin. Expression of lncRNA SOX21-AS1 and miR-875-5p in glioma tissues and relationship with prognosis of patients [J]. Laboratory Medicine, 2024, 39(3): 209-214. |
[7] | ZOU Chen, XU Runhao, DING Yi, ZHANG Jie, WENG Wenhao, WANG Zhenhua, CAO Yun. Colorectal cancer screening model based on ProteomeXchange database [J]. Laboratory Medicine, 2024, 39(12): 1181-1189. |
[8] | WANG Zhaohui, ZHENG Zhenlu, LI Ruina, MA Yuanyuan, XU Hui, WEI Zhenhong, JIA Yanjuan, QI Xiaoming, GAO Xiaoling. Study of latent tuberculosis infection mechanism of DosR antigen Rv2626c inducing macrophage activation through lncRNA MacORIS [J]. Laboratory Medicine, 2024, 39(10): 923-932. |
[9] | ZHANG Feifei, WANG Jingwen, ZHANG Yuexin, ZHENG Dawei, MEN Xiang. Correlation between lncRNA MIR155HG and pulmonary function in patients with COPD and its auxiliary diagnosis value for AECODP [J]. Laboratory Medicine, 2024, 39(1): 31-36. |
[10] | LAN Jun, LU Shuting, YANG Jianrui. Roles of serum IL-26 and IL-27 levels in patients with colorectal cancer [J]. Laboratory Medicine, 2024, 39(1): 7-12. |
[11] | LI Liangshan, ZHAO Hu, WANG Shiwen. Screening potential prognostic biomarkers of colorectal cancer based on weighted gene co-expression network analysis [J]. Laboratory Medicine, 2023, 38(9): 825-832. |
[12] | ZHU Rixiang, YIN Jie. Relationship between soluble growth stimulating gene 2 protein and clinicopathological features and prognosis in patients with colorectal cancer [J]. Laboratory Medicine, 2023, 38(7): 629-633. |
[13] | WANG Tengfei, CHEN Shan, AN Hebing, ZHOU Lei. Expressions and roles of lncRNA CRNDE and miR-384 in peripheral blood of patients with acute leukemia [J]. Laboratory Medicine, 2023, 38(7): 686-691. |
[14] | JIANG Mengying, LIU Yiwen, HE Yiqing, XU Jing, YANG Cuixia, GAO Feng, DU Yan. Clinical role of serum S1P in the early diagnosis of colorectal cancer [J]. Laboratory Medicine, 2023, 38(4): 307-312. |
[15] | ZHANG Guoliang, LIU Yiwen, HE Yiqing, XU Jing, YANG Cuixia, GAO Feng, LIU Hua. Roles of serum HYAL1 and HA in the auxiliary diagnosis and therapeutic monitoring of colorectal cancer [J]. Laboratory Medicine, 2023, 38(4): 313-319. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||